AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

CARCLO PLC

Delisting Announcement Jan 2, 2020

5252_rns_2020-01-02_f0ec70ed-8b49-497f-97ee-d7c2d6f6c879.html

Delisting Announcement

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

You don't have Javascript enabled. For full functionality this page requires javascript to be enabled.

RNS Number : 4657Y

Carclo plc

02 January 2020

2 January 2020

Carclo plc

("Carclo" or the "Group")

Suspension of share listing

Following the publication of Carclo's annual report and accounts for the year ended 31 March 2019, on 13 November 2019, the Group has been working to finalise the interim results for the six months ended 30 September 2019 (the "Interim Results"). Unfortunately, the impact of the delay to the publication 2019 annual results, together with the work required to conclude the successful exit from the Wipac business, has meant that the Group was not able to publish the Interim Results by 31 December 2019 as required under the Disclosure & Transparency Rules.

As a result, the Company announces that it has requested the suspension of the listing of the Company's ordinary shares with effect from 07:30 today, pending the publication of the Interim Results.

Preparation of the Interim Results is well advanced and the Company will seek to publish these as soon as possible.  Further announcements will be made as appropriate.  

Enquiries:
Carclo plc                                                          01924 268040
Mark Rollins - Chairman

FTI Consulting                                                  020 3727 1340

Nick Hasell / Susanne Yule

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

END

SRSUPURWGUPUGCG

Talk to a Data Expert

Have a question? We'll get back to you promptly.